Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with breast cancer or at high risk of developing it

被引：0
|
作者：
Sestak, I.
Harvie, M.
Howell, A.
Forbes, J. F.
Dowsett, M.
Cuzick, J. M.
机构：
[1] Univ London, London, England
[2] Wythenshawe Hosp, Nightingale & Genesis Prevent Ctr, Manchester M23 9LT, Lancs, England
[3] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[4] Univ Newcastle, Australian New Zealand Breast Canc Trials Grp, Newcastle, NSW 2300, Australia
[5] Royal Marsden Hosp, London SW3 6JJ, England
[6] Wolfson Inst Prevent Med, EMS, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 27期
关键词：
D O I：
10.1200/jco.2011.29.27_suppl.165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
165
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer
    Ivana Sestak
    Michelle Harvie
    Anthony Howell
    John F. Forbes
    Mitch Dowsett
    Jack Cuzick
    [J]. Breast Cancer Research and Treatment, 2012, 134 : 727 - 734
  • [2] Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer
    Sestak, Ivana
    Harvie, Michelle
    Howell, Anthony
    Forbes, John F.
    Dowsett, Mitch
    Cuzick, Jack
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 727 - 734
  • [3] Breast cancer prevention using anastrozole in postmenopausal women at high risk
    Cuzick, J.
    Sestak, I.
    Forbes, J. F.
    Dowsett, M.
    Knox, J.
    Cawthorn, S.
    Saunders, C.
    Roche, N.
    Mansel, R. E.
    von Minckwitz, G.
    Bonanni, B.
    Palva, T.
    Howell, A.
    [J]. CANCER RESEARCH, 2013, 73
  • [4] Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women
    Thürlimann, B
    Robertson, JFR
    Nabholtz, JM
    Buzdar, A
    Bonneterre, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (16) : 2310 - 2317
  • [5] Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer
    Boccardo, F.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (02): : 76 - 77
  • [6] Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer
    Francesco Boccardo
    [J]. Nature Clinical Practice Oncology, 2008, 5 : 76 - 77
  • [7] Pharmacoeconomic aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective
    Piskur, R.
    Sonc, M.
    Cufer, T.
    Borstnar, S.
    Mrhar, A.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 75 - 75
  • [8] Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
    Bago-Horvath, Zsuzsanna
    Rudas, Margaretha
    Dubsky, Peter
    Jakesz, Raimund
    Singer, Christian F.
    Kemmerling, Ralf
    Greil, Richard
    Jelen, Andrea
    Boehm, Gerhard
    Jasarevic, Zerina
    Haid, Anton
    Gruber, Christine
    Poestlberger, Sabine
    Filipits, Martin
    Gnant, Michael
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7828 - 7834
  • [9] Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology
    Gerber, B
    Krause, A
    Reimer, T
    Mylonas, I
    Makovitzky, J
    Kundt, G
    Janni, W
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1245 - 1250
  • [10] Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer
    Sawada, S
    Sato, K
    Kusuhara, M
    Ayaori, M
    Yonemura, A
    Tamaki, K
    Hiraide, H
    Mochizuki, H
    Ohsuzu, F
    [J]. ACTA ONCOLOGICA, 2005, 44 (02) : 134 - 141
12345